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Abstract—Common chronic conditions are routinely treated following
standardised procedures known as clinical pathways. For patients suffer-
ing from two or more chronic conditions, referred to as multimorbidities,
several pathways have to be applied simultaneously. However, since
pathways rarely consider the presence of comorbidities, applying several
pathways may lead to potentially harmful (medication) conflicts. This
paper proposes an automated framework to detect, highlight and resolve
conflicts in the treatments used for patients with multimorbidites. We use
BPMN as a modelling language for capturing care guidelines. A BPMN
model is transformed into an intermediate formal model capturing the
possible unfoldings of the pathway. Putting together the constraint solver
Z3 and the theorem prover Isabelle, we combine treatment plans and
check the correctness of the approach. We illustrate the approach with
an example from the medical domain and discuss future work.
1 INTRODUCTION
In healthcare management and practice, as in other domains,
clinical and medical procedures are streamlined by adopting
standardised guidelines. In particular, treatments for com-
mon chronic conditions have been subject to various clinical
trials, and the outcomes documented in clinical pathways (CPs)
specifying accepted treatment steps, possible alternatives,
and recommendations to follow. In Scotland, over half of all
people with chronic conditions have two or more conditions
simultaneously, also known as multimorbidity [22]. When
managing the treatment plans for patients with multimorbid-
ity, the problem is how to resolve possible contradictions
that may arise when combining several CPs. Usually, a
CP does not consider the presence of comorbidities and
possible consequences of interactions with other pathways
are mostly ignored. There is little information on how to
handle conflicts when they arise. Improving the care of
patients with multimorbidity is a global concern. In the
UK, the National Institute of Health and Care Excellence
(NICE) publishes CPs for most well known conditions,
including a recent general guidance on multimorbidity1.
These guidelines, which underly our work, are given in
1. NICE www.nice.org.uk
a combination of visual diagrams and natural language, and
capture the steps and decision points taken in the treatment
of a disease. They are essentially process descriptions and, to
remove some of the inherent ambiguity in these diagrams,
we use BPMN (Business Process Modeling Notation) [8] to
describe them. Our contribution in this paper is an integrated
formal framework to detect, highlight and resolve conflicts in
the treatment of patients with multimorbidity, consisting of:
1) A front-end component, offering an interface to manipulate
the information contained in existing CPs as BPMN models
(generating JSON output). 2) A formal model to capture the
semantics contained in the structure and annotations of the
CPs extracted from the front-end stage. This model should
be suitable for expressing multiple CPs and formulating
the co-existence of conflicts across pathways. 3) A back-end
component, implementing the formal model, and capable
of applying it to the particular instances of CPs coming
from the front-end. This component applies constructions
of the formal model to compute and represent the relevant
notions of pathway conflicts. 4) A verification component to
formally verify the back-end (e.g., to validate its correctness
wrt specifications, expected behaviour, etc).
We use labelled event structures (LES) [25, 16] for the
semantics, a mixture of higher-order logic (HOL, a simply
typed, functional language to write code and formal proofs),
and SMT-LIB [9] (a standardised first-order logic language
to interface with many SAT and satisfiable modulo theory
(SMT) solvers) for the back-end. This hybrid implementa-
tion allows us to: (i) choose between a HOL computation
(either directly in the theorem prover Isabelle or in one of
the functional languages Isabelle can generate) and SMT
solvers; (ii) formally verify our back-end using HOL and
applying formally proven theorems to it (using Isabelle). To
communicate between the front-end and the back-end, we
use a straightforward JSON format describing a pathway
in terms of its LES semantics. Paper structure: Section 2
describes the front-end and how a BPMN model is converted
into a LES. Section 3 shows the back-end concentrating on
conflict resolution, illustrated with an example in Section 4.
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2 THE FRONT-END MODULE
In practice, CPs are presented in natural language with
additional diagrams as shown in Figure 1. When click-
ing on individual nodes (as the highlighted one), further
information is typically shown in text on the right hand
side of the diagram. When reasoning over pathways, these
Fig. 1. Managing blood glucose in adults with type 2 diabetes (NICE)
need to be captured more precisely through domain-specific
modelling languages or general-purpose languages such as
BPMN or UML Activity Diagrams [7]. Although none of
these languages has been proven to be perfectly compatible
with clinical pathway process modelling, BPMN is regarded
as a promising notation amongst process-oriented modelling
languages. Hashemian and Abidi analysed various tech-
niques and picked out the main features in a comparison
of BPMN with other approaches [12]. Reasons why BPMN
attracts attention include its broad acceptance within research
and industry, compatibility with various process modelling
tools, expressiveness, and simple notation [12, 5]. Thus, it
is natural to interface with this format and its intended
semantics. The input to our front-end module is a BPMN
file in XML format. The module produces a JSON file, in
a specific format, describing the corresponding LES used
by the back-end component (Section 3). It also produces a
graphical representation of the LES and, with feedback from
the back-end, can alter such a representation to highlight
conflicts. This intermediate LES representation still has to
be converted back onto a BPMN model or more suitable
visualisation mechanisms for clinicians. Note that this last
step is outside the scope of the present paper and requires
clinical evaluation. For space reasons we omit the BPMN
associated to Figure 1. Figure 2 shows a simple BPMN of a
process starting with a parallel gateway (splitting the control
flow) where the top branch involves Task 1 followed by
a choice (exclusive gateway) between Task 3 or Task
4, followed by a merge and by Task 6. Task 2, in the
lower branch, is executed in parallel, and the process ends
after merging back the branches in the parallel gateway.
No conditions are shown here but could be present in an
exclusive gateway.
Fig. 2. A simple BPMN example
The front-end module works by extracting knowledge
from a given pathway in accordance to a specific ontology,
and by mapping elements of this ontology into LES concepts.
We introduce the ontology in Section 2.1, LES briefly in
Section 2.2, and a description of the mapping in Section 2.3.
2.1 BPMN CP Ontology
We follow [12], where ontologies (representing entities, their
properties and mutual relationships) are established for both
BPMN and clinical pathways. A CP ontology describes a
number of specific constructs including branching by a deci-
sion, branching for multiple concurrent treatments, activity
flows, and so on, as follows. Action_Step is a clinical ac-
tivity to be performed. Decision_Step denotes a decision
point to determine the next possible Action_Step along the
pathway. Route_step involves a possible split/join of the
activity flow. This includes Branch_Step when branching
the flow so multiple steps can be performed in parallel, and
Synchronization_Step, which joins the flows back into
one. Data_element is an attribute of all classes, containing
all the needed domain-specific information.
The BPMNCP ontology is a subset of the BPMN onto-
logy for representing clinical pathways. Each element has
common attributes id and name, one incoming flow (except
Start_Event) and one outgoing flow (except End_Event).
An event is an occurrence in the pathway: Start_Event
is the initial event of the pathway, End_Event specifies
the end of the pathway, and Intermediate_Event is any
other kind of event, triggered by a certain cause. Activity is
a general term for actions done in the process. Every action
taken by an actor or participant is an activity. Hence, each
Action_Step is mapped as an activity.
• Task represents a job to be performed in the process
and can be regarded as a unit of work. An atomic
Action_Step can be described as a Task.
• Sub-Process is any decomposable activity. The in-
ternal details are modelled using Flow Objects [8] of
Gateways, Sequence_Flow, Activities, and Events.
3In other words, it contains a valid BPMN diagram
inside it. Hence, a modularised Action_Step can be
described as a Sub-Process.
Gateways are used for depicting diverging flows and con-
verging flows. Typically, diverging gateways allow single
input and multiple output while converging gateways take
multiple inputs and generate a single output.
Exclusive_Gateway controls mutually exclusive flows.
Exactly one of the subsequent paths is valid for diverg-
ing branches. So Exclusive_Gateway (diverging) appears
where there is a Decision_Step. Exclusive_Gateway
(converging) may appear in case subsequent common el-
ements exist for the branches split by the divergence ap-
pearing earlier. Parallel_Gateway controls multiple tasks
to be completed to proceed. All the branches exiting a
diverging Parallel_Gateway are joined by a converging
Parallel_Gateway at some point, and to proceed on from
the converging point the completion of all the incoming
branches is a necessary condition. Thus, diverging and con-
verging Parallel_Gateway represent Branch_Step and
Synchronization_Step respectively. Sequence_Flow is
a kind of Connection Object, representing the flow between a
pair of other elements above. It is defined using sourceRef
for indicating its source element and targetRef for indi-
cating its target element. This represents the flow relation
between each step in a CP. This is used to provide data de-
scription on each element. In [12], Property is defined just
to deliver or store any generic additional data; even though
BPMN provides the possibility of specifying name, type and
value of variables in Property, we need to describe logical
and arithmetic general formulas to be passed to the SMT
solver. To this end, we chose to store such information in the
Documentation field, specifying a format for the possible
entries, and handling all the details to interface the final user
with the back-end: for example, converting the user-friendly
infix notation with the Polish notation used in SMT-LIB.
2.2 Labelled event structures (LES)
The model we use to capture the interleaving and relation-
ships between events in a given BPMNCP is a labelled
(prime) event structure [25] or LES for short. What appeals to
this model is its simplicity and ability to naturally describe
fundamental notions present in such diagrams including
sequential, parallel and iterative behaviour (or the unfold-
ings thereof) [16, 2]. LES offer simple notions over sets of
events to denote event occurrences together with binary
relations for expressing causal dependency (causality) and
nondeterminism (conflict). Causality implies a (partial) order
among event occurrences, while conflict expresses how the
occurrence of certain events excludes the occurrence of
others (e.g., an event occurring in one branch of a diverging
exclusive gateway excludes events in another branch). From
the two relations defined on the set of events, a further
relation is derived, namely the concurrency relation. Two
events are concurrent if and only if they are completely
unrelated, i.e., neither related by causality nor by conflict.
This relation makes it straightforward to represent parallel
BPMN gateways. The formal definition (cf. [16]) is as follows,
where traces of execution are maximal configurations.
Fig. 3. Type 2 Diabetes LES when metformin is tolerated
Definition 1. An event structure is a triple E = (Ev,→∗,#)
where Ev is a set of events and →∗,# ⊆ Ev × Ev are
binary relations called causality and conflict, respectively.
Causality →∗ is a partial order. Conflict # is symmet-
ric and irreflexive, and propagates over causality, i.e.,(
e#e′ ∧ e′ →∗ e′′
)
⇒ e#e′′ for all e, e′ , e′′ ∈ Ev. Two
events e, e
′ ∈ Ev are concurrent, e co e′ iff ¬(e →∗
e
′ ∨ e′ →∗ e ∨ e#e′). C ⊆ Ev is a configuration iff (1)
C is conflict-free: ∀e, e′ ∈ C¬( e#e′) and (2) downward-
closed2: e ∈ C and e′ →∗ e imply e′ ∈ C .
Event structures are enriched with a labelling function µ :
Ev → 2L that maps each event onto a subset of elements
of L. This labelling function is necessary to establish a
connection between the semantic model (event structure)
and the syntactic model it is describing (here BPMNCP ).
A labelled event structure is a pair L = (Ev, µ). The set
L can be an arbitrary set depending on the domain of use.
Here, labels either denote formulas (constraints over integer
variables, e.g., x ≤ 10, y = 5, or HbA1c ≤ 48) or logical
propositions expressing actions or patient conditions (e.g.,
perform blood test, metformin not tolerated, and so on).
Figure 3 shows the graphical output (using the JUNG
framework [21]) of the LES for type 2 diabetes; an internal
event is coloured (e.g., E_1) if it marks the beginning of
an alternative, and events show the label (medication) asso-
ciated (e.g., metformin and DPP4 for T_4).The figure was
obtained by manually converting a NICE pathway into a
BPMN model (not shown here for space reasons, but visible
at https://sites.google.com/site/tase8prfafyz7v/), and then
applying our front-end to translate into an LES.
2.3 From BPMN to LES
We describe the ontology mapping between BPMN and LES.
We use (a subset of) the BPMN ontology workflow elements
from [12], mapped to LES as follows:
• Start_Event, End_Event, and Task elements are
regarded as events in the event structure.
2. The terminology reflects the fact that the arrow symbol →∗ is
commonly considered, by convention, to go from a greater event to a
smaller one, according to the partial order it defines. In this paper, this
convention has no particular significance.
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Start_Event and End_Event to predecessor
and successor of the Sub-Process. Elements in the
Sub-Process are regarded as normal.
• A diverging Exclusive_Gateway is mapped to an
event and all successor elements, which are indi-
cated by the outgoing flows of the targeted diverging
Exclusive_Gateway, are defined to be in conflict (#).
• Converging Exclusive_Gateway is mapped to an
event. Targeted converging Exclusive_Gateway and
all the following elements generate separate paths to the
End_Event, each connected to each of the predecessor
element, which is the element indicated by the dedicated
incoming flow.
• A diverging Parallel_Gateway is mapped to an
event and all the successor elements, which are indi-
cated by the outgoing flows of the targeted diverging
Parallel_Gateway, are regarded as events which can
occur concurrently.
• A converging Parallel_Gateway is regarded as
a merging event in the event structure. If a pair
(diverging-converging) of Parallel_Gateways in-
cludes any pair of Exclusive_Gateways in it, the
converging Parallel_Gateways have multiple op-
tions for the incoming flow which follows the pair of
Exclusive_Gateway. This process is repeated in case
of further nested pairs.
• A Sequence_Flow element corresponds to a pair in
the causality relation of the event structure.
• Any Property used for domain-specific data descrip-
tion on the element is regarded as a label for the
corresponding event.
Due to the fundamental LES condition on the propagation
of conflicts (see Definition 1), the mapping of a diverging
exclusive gateway generates a cascaded duplication of all
subsequent events in the corresponding event structure, as
can be seen in the example of Fig. 3. Our automated BPMN
to LES transformation deals with this by unfolding the paths
of the original BPMN when exclusive gateways are present.
To illustrate this, consider a simple example (Fig. 4) with
two diverging exclusive gateways (E1 and E3) executed
in parallel. The algorithm proceeds by first unfolding one
of them (say E1),3 thereby duplicating all the nodes fol-
lowing its corresponding converging gateway (E2). Since
the causality relation is transitive, this duplication must be
followed by a duplication also of the edges heading into all
the nodes following the converging node (P2) corresponding
to P1, since P2 has an incoming edge from E2. The results
of this first duplication round are drawn in Fig. 4(b), where
the nodes and the edges originating the duplication are
greyed out. Now we have to iterate the process for the
pair E3, E4, which must happen keeping in consideration
the duplication spawned in the previous step (Fig. 4(c)).
After unfolding, the structure goes through a procedure
which trims the graph as follows. As seen in Fig. 4(d), there
still remain nodes having no path to them or succeeding
an invalid node: those are marked as not effective, and
3. This choice is made with no particular criterion. Introducing such
a criterion, or unfolding E1 and E2 in parallel, might improve the
algorithm; however, we have not investigated such matters yet.
will be ignored when the final structure is generated. For
example, E2 and E4 lost all the incoming flows to them and,
therefore, all the following nodes are not effective. Also, there
are some meaningless nodes remaining: all the converging
Exclusive_Gateway are not necessary after unfolding,
because they do not join flows any longer. Furthermore,
Start_Event and End_Event have no role after flattening.
Thus, all these nodes are removed from the structure.
3 THE HYBRID HOL/SMT-LIB BACKEND
Isabelle [20] is a theorem prover or proof assistant which
provides a framework to accommodate logical systems (de-
ductive rules, axioms), and compute the validity of logical
deductions according to a given system. HOL is one of the
most commonly used logical systems in Isabelle, and the
resulting combination is called Isabelle/HOL. In the sequel,
when we write Isabelle, we will mean Isabelle/HOL.
An SMT solver is a computer program designed to check
the satisfiability of a set of formulas (known as assertions)
expressed in first-order logic, where for instance arithmetic
operations and comparison are understood, and additional
relations and functions can be given a semantic meaning
in order to make the problem satisfiable. Well-known SMT
solvers include CVC3, CVC4, MathSAT, Yices, Z3 [9].
Specifying LES in Isabelle is straightforward. We need
to define relations for causality Ca and conflict Co, and
their properties. For instance, Ca is a partial order (reflexive,
antisymmetric and transitive) and Co is irreflexive, symmet-
ric and propagates over causality. The propagation of Co
over Ca, referred to as Propagation, is given below as an
example.
abbrev ia t ion ” Propagation Co Ca ==
(∀ x y z . ( ( Co x y & Ca y z ) −→ Co x z ) ) ”
Further, the following allows us to talk about an LES
satisfying all required properties.
abbrev ia t ion ” IsLes Ca Co == ( Ref lex Ca &
Antisym Ca & Trans Ca & I r r e f l Co &
Sym Co & Propagation Co Ca ) ” .
In other words, IsLes is a higher-order function re-
turning whether Ca and Co form a valid LES: besides the
propagation property we have just seen, there are reflexivity,
antisymmetry, irreflexivity, symmetry, and transitivity. Given
this definition (which conforms to Definition 1), we can take
advantage of Isabelle’s built-in SMT code generator to exploit
SMT solvers’ powers for checking whether a given model is
a valid LES. We make use of this feature to check whether
the LES obtained automatically from a given BPMN model
is correct. This extra checking step allows to have a formal
verification that the original CP was correctly captured into
a BPMN, and that the front-end produced consistent output.
Moreover, such formal specification can be used for further
computations regarding the composition of several CPs. See
[3] for further details. We also use Isabelle and SMT solvers
to detect inconsistencies in the LESs generated automatically
from two or more (single disease) BPMN models and propose
resolutions. An inconsistency arises from the event labels
of different models, such as when the actions associated
to the events should not occur together (for instance, two
medications usually administered for different treatments are
5(a) BPMN diagram (b) Unfolding the first branch of P2
(c) Unfolding the second branch of P2 (d) Result of unfolding
Fig. 4. Unfolding Exclusive_Gateway
harmful when combined). Finding conflicts between different
event labels must also consider the arithmetic constraints
associated to the events and check whether they are pairwise
unsatisfiable. Such constraints can denote critical bounds
concerning a blood value, medication dosage, and so on.
Consider a simple example where an event T_4 has a
label given by z>1, which would be translated into (assert
(> z 1)) for the back-end. Assume that in a different CP
we have an event Q_8 with a label given by z<-10 which
would generate a similar assertion, passing it along with the
former to the SMT solver. The SMT solver would detect a
conflict and output the pairs of events in conflict (in this
case, T_4 and Q_8), along with the reason of the conflict (the
two inconciliable arithmetic statements about the variable z).
This is done for every possible combination of events, and
passed back to the front-end for a graphical representation of
the conflicts. For instance, if any of the medications used for
type 2 diabetes as in Figure 3 cannot be given together with a
medication for another condition, we show this back through
the JUNG framework using red coloured events (omitted
here for space reasons).
We proceed to enrich this semantics framework with a
more powerful notion of conflict. In practice, the adverse
effect of interactions between treatments such as the one
derived from different medications that should not be given
together is often expressed by a degree of severity (as we
did in [15]) but in addition, rather than to highlight every
single event with a conflict, we only care about the actual
events that realistically denote concurrent treatment actions
at a certain moment of time. We will see how to reconcile
our LES semantics with this consideration, using an SMT
solver. In doing so, we add a notion of time to our LES
semantics, and compute the concurrent execution of distinct
CPs minimising the degree of conflict.
Formally, we consider the directed acyclic graph (DAG)
structure corresponding to an event structure partial order,
described by its covering relation T (i.e., the node n2 is a
child of the node n1 iff (n1, n2) ∈ T ). This correspondence is
always possible for a finite partial order. We also weigh its
edges through a map w : T 7→ N. (T0, . . . , TN ) is a given list
of such DAGs, each representing a CP unfolding. The nodes
are the single steps of each CP, the edges describe how they
are causally connected, while the weights model the time
elapsed between the occurrence of subsequent steps. The idea
is that we want to take into account the temporal separation
between the occurrence of two conflicting prescriptions (e.g.,
Insulin for diabetes versus Eprosartan for hypertension) for
a more realistic resolution of such conflicts, by computing
a global score taking into account all the possible conflicts
between the pair of executed nodes, along with the time
separating them. To this end, we need to consider all possible
paths from the source of each Ti to each of its sinks, and pick
exactly one such path for each i, while maximising the global
score [1]. We hence have two problems: how to describe the
notions of DAG and of path in SMT; and how to compute
the score, taking time into account.
Paths There are well-known, efficient ways of computing
paths in a given DAG. However, we do not need to separate
the problem in the two steps consisting of finding all possible
paths, and then of picking the maximising one among them:
we can express the whole problem as an SMT problem and
solve it in one shot. This subsection explains how the first
part of the problem is encoded into SMT, while the next
illustrates how this is done for the second part.
We are given the covering relations of the DAGs, which we
can consider as one relation being the union thereof, and we
6want to describe the paths solving our problem. We create
boolean variables n1 . . . nN , one for each node: a path will
be described by an assignment to them. We must pick all
the sources of the Ti’s, so that the corresponding ni’s will
be asserted to be true. Then, for each source, we must assert
that exactly one of its children must be true. Then, for every
child set to true, we must ask that exactly one of its children
must be true, and so on, until no node has child (we reached
a sink). Besides doing that, we want to make sure that no
other node is selected. Correspondingly, we generate, for the
node ni, the assertions
ni →
∨
j|(i,j)∈G
 ∧
k 6=j,
k|(i,k)∈G
(¬nk) ∧ nj
 and ∧
(j,i)∈G
(¬nj)→ ¬ni. (1)
Scores We introduce an integer SMT variable clocki for each
node, and for each i, j such that j is a child of i, we create
the following assertion:
ni ∧ nj → clockj = clocki+w (i, j) .
Now we can introduce two kinds of scores, represented by
integer SMT variables scorei,j and scorei, respectively. The
first are the scores generated by possible conflicts between
the prescription associated to each event of the pair, while
the second are the absolute improvements given by the
prescription associated to each step. We first zero out the
scores for the unselected nodes:
¬ni → scorei,j = 0 ∧ scorei = 0 ∧ scorej,i = 0.
Since the variables ni describe whether a node has been
selected in the final optimisation, we generate the following
assertions for each possible i, j:
ni ∧ nj → scorei,j = f (interactioni,j , |clocki− clockj |) ,
where interactioni,j are constants obtained by looking up
a database consulting a database to obtain the degree of
conflict between the treatments in ni and nj . f is a known
function which is used to specify how the interaction between
different treatments and the elapsed time combine together.
We finally assign the sum of the scorei,j and of the scorei to a
variable, and ask for an SMT solution to all the assertions for
the ni’s maximising the global score. By varying f , the SMT
code can be used for different goals: • when f is a threshold
function, firing as soon as the combination of interaction and
temporal closeness of two steps is below a given limit, the
SMT will return for each pair of nodes a conflict relation
between the event structures representing CPs; • when f is a
function expressing the degree of interaction between steps
in two CPs, the SMT will return the execution of the two CPs
maximising the total score (i.e., minimising the conflicts).
The constants interactioni,j assign a degree to the con-
flicts used to select the best option. This assignment, together
with f , determines how the conflicts influence the resulting
LES and the execution of CPs.
Conceptually, ni, clocki, scorei represent corresponding
functions (as i ranges in {1, . . . , N}) over the set of all nodes.
Technically, however, they are expressed as distinct SMT
boolean (respectively, integer) variables, one for each node,
for performance reasons. In general, we found that choosing
the right way, between equivalent ones, of expressing SMT
assertions can result in dramatic performance difference. The
choice of separate variables rather than functions over all
the nodes to represent such notions is a case of this general
phenomenon. Another advantage of this representation is
that it saves us from using quantifiers. This is especially
relevant in the case of Assertions (1) to find paths: the most
natural rendition in SMT of the concept of path is probably
one relying on universal and existential quantifiers. Instead,
we repeat Assertions (1) over all the relevant nodes. This
improves performance, but comes at the price of expressing
the concept of path in a less intuitive way. In contrast, the
assertions above regarding clocki, scorei and scorei,j are
themselves simple. A slight complication came from the
fact that, while the uninterpreted SMT addition operator
supports any finite number of operands, there is no direct,
efficient way of summing over an intensionally defined
set. Since our final goal is the maximisation of the sum
of all scorei and scorei,j , we had to explicitly enumerate
all the possible scorei and scorei,j as operands of +, and
ask Z3 to maximise the result. Overall, this way of for-
malising the concepts of path, scores and clock does not
make use of quantifiers, rational or real arithmetics, arrays,
uninterpreted sorts or functions; however, it needs integer
arithmetics. Correspondingly, a sub-theory of the main SMT-
LIB theory suffices when invoking the SMT solver to process
our assertions, for example QF_NIA (quantifier-free integer
arithmetics); one can even get away with smaller theories as
QF_LIA (quantifier-free linear integer arithmetics) according
to how the function f behaves. This helps the solver applying
satisfiability techniques specialised to the given fragment of
theory, and typically more efficient [9].
The possibility of varying interaction and f , and the
abstractness of the notion of time in our approach add
flexibility to it. However, the expertise of a clinician will be
needed to adapt and tune these aspects to a particular patient;
issues that she will need to consider include: 1) Durations
can be typically expressed using a wide range of time scales
(minutes, hours, days) for different kinds of actions in a CP.
Such durations will need to be converted into a suitable
common time unity in order to be applied the present
approach. 2) Durations are often not explicit in CPs, also
because they can depend subtly on the particular patient
(e.g., if a drug needs to be taken frequently, subsequent
administrations should be represented by distinct graph
vertices, separated by edges with suitable weights, where the
weights guarantee that the minimum prescribed time passes
between subsequent administration). While some work has
been done in data mining action durations in CPs [17], the
domain expert has a key role in assigning suitable durations
to apply our model. To this end, further work will be needed
to involve domain experts for advice and feedback on how
to make the mechanisms described above usable by them.
4 EXAMPLE: DIABETES AND HYPERTENSION
As an application of the whole approach, we take the NICE
CPs for type 2 diabetes and hypertension. These are two of
the CPs considered in a medical study involving a woman
with five multimorbidities given in [4]. The results are shown
in Figure 5, where the hypertension event structure is shown,
and the node h/T_2 is selected (the node names are gener-
ated automatically during conversion from BPMN). For that
7Fig. 5. The interactive conflict explorer
figure, after obtaining all of the possible conflicts we assigned
them arbitrary severities and added possible weights of the
edges (describing the time between each node). The user can
click a node to select it and access information regarding
the conflicting nodes, the severity, etc. . . ; the starting node’s
name is written in a bigger font, and the selected node is in
red. The interface (based on Cytoscape [24]) interacts with
the back-end, and then represents nodes with more severe
conflicts as bigger. Both event structures are represented,
and the user can double-click on one of them to collapse it
(as is the case for the diabetes one in the lower-left corner
of the figure, where only the hypertension is expanded). In
this case, fainter lines going from the expanded structure to
the collapsed one denotes the presence of conflicts. When
the user expands the collapsed event structure, they can
see the edges between the two structures representing the
conflicts, in addition to the causality ones. Moreover, the
optimal execution path (i.e., that minimising conflicts) is
highlighted by triangle-shaped nodes, to suggest a possible
future therapy to the user. Full details of the example cannot
be shown here for space reasons. We refer the interested
reader to our webpage4.
5 RELATED WORK
Several formal representations of CPs have been borrowed
from computer science. We can distinguish two categories.
The first one is a direct formal modelling of CPs, while the
second passes through a formal analysis of BPMN, as an
intermediate notation from CPs to formal models. Han et al.
[11] and Yang et al. [27] use Performance Evaluation Process
Algebra (PEPA) [13] combined with coloured stochastic Petri
nets for computing CPs. Clinical Pathway PEPA (CPP) [11]
makes it possible to analyse, simulate, and optimise the
CPs quantitatively. The main view of this analysis of CPs is
to figure out bottlenecks and optimise allocation of hospital
resources, such as medical staff and equipment. In [27], PEPA
is also employed for the analysis of CPs, and essentially only
addresses resource allocation. Note that our use of CPs here
is very different as we are describing evidence-based proce-
dures for the treatment of well understood chronic conditions.
Our pathways as documented by NICE do not include
probabilities and a quantitative analysis is thus not applicable.
BPMN is used in many domains and has a natural semantics
defined in terms of Petri nets [10]. Our use of labelled
event structures in our work is in line with this semantics,
4. https://sites.google.com/site/tase8prfafyz7v/
since event structures can be understood as the unfoldings
of Petri nets [19]. Further different approaches provide a
semantics for BPMN based on Event-B [6] and PROMELA
[26] making it possible to apply the underlying techniques
for property verification. In the case of using PROMELA,
the model checker SPIN [14] enables the verification of
livelocks, deadlocks and LTL properties over BPMN mod-
els. The problem of automated detection and resolution of
pathway conflicts in patients with multimorbidity is gaining
considerable attention. In [15], the authors look at medication
conflicts specifically and use the SMT solver Z3 to find the
conflicts and automatically suggest alternatives based on a
notion of score associated to medications. Constraint logic
programming (CLP) is proposed to express and deal with
conflicts in [18] . While CLP solvers and SMT solvers have
fundamental similarities, their expressiveness, background
technologies and domains of application differ. With the
efficiency of the current, mutually competitive, SMT solvers
constantly growing, their lower expressiveness is getting
more and more effectively compensated. And our hybrid
approach adds to this compensation, with the availability of
the highly expressive HOL language.
6 CONCLUSIONS
The problem of combining multiple clinical pathways for pa-
tients with multimorbidity poses a broad range of challenges.
It is important to find a combination of formalisms able to
capture pathways, reason about their possible combinations
and highlight problems. In this paper, we proposed an
automated approach which addresses these challenges. The
front-end module exposes the BPMN format to the user.
The motivation for the choice of BPMN is that it is widely
adopted for process modeling in industry and economy; its
application to the healthcare domain has been intensively
studied in the last years and, in particular, has been found to
be suitable for the modeling and imaging of actual CPs [23].
While the current graphical representation is still too prim-
itive to be directly usable by domain experts, it is a first
step, upon which interactivity (e.g., zooming on relevant
portions of the representation) and filters (e.g., displaying
only events related to selected conflicts) are being added in
order to address the problem of the exceeding number of
conflicts potentially being presented to the user, with the aim
of making it human-manageable.
An hybrid back-end integrating components written in
SMT-LIB and components written in HOL, thus allowing
to choose the most convenient language for a given task, is
used for semantic analysis and conflict detection. The link
between the two languages used in the back-end relies on
gateway definitions and on Isabelle’s internal SMT generator,
and is facilitated by the simple JSON format we adopted to
present clinical pathways to the back-end, which is designed
to be accessible from both languages. It should be noted
that Isabelle’s SMT generator is used internally to use SMT
solvers as automated deduction tools, and is not conceived
to be exposed to the user. We believe that a novelty of the
proposed approach is to show how this Isabelle feature can be
more useful than that, by acting as a link between the two lan-
guages we use, and to use the highly expressive higher-order
logic to both ease the definitions and prove the correctness of
8our LES definitions in both higher-order logic and SMT code.
Indeed, in this paper Isabelle’s SMT generator is not used for
the goal it was originally conceived for (theorem proving),
but rather to generate SMT code for directly solving some
aspects of our main problem (combination of CPs). Finally,
our approach permits to employ the LES semantics event in
the presence of quantitative conflicts, adds a notion of time to
the execution of pathways, and permits to suggest to the user
executions which minimise the conflict. There are several
fronts for possible future work; first, the idea of exploiting
Isabelle’s internal SMT generator to check the correctness of
SMT code can be, we believe, far-reaching, and will be used
to cover further SMT developments. Secondly, the back-end
execution time is, for the presented example, 3-4 seconds on
average on a standard laptop, thereby giving the possibility
of real-time computational adjustments based on feedback
from the user and specific parameters: for instance, updating
the weights on the edges to reflect the actual time separations
for the nodes already visited by a given patient, or imposing
the passage on nodes selected by the user.
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